These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 30774080)
1. [VEGF-C and lymphatic vessels: a double-edged sword in tumor development and metastasis]. Ndiaye PD; Pagès G Med Sci (Paris); 2019 Feb; 35(2):132-137. PubMed ID: 30774080 [TBL] [Abstract][Full Text] [Related]
2. Role of lymphangiogenic factors in tumor metastasis. He Y; Karpanen T; Alitalo K Biochim Biophys Acta; 2004 Mar; 1654(1):3-12. PubMed ID: 14984763 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor C is required for sprouting of the first lymphatic vessels from embryonic veins. Karkkainen MJ; Haiko P; Sainio K; Partanen J; Taipale J; Petrova TV; Jeltsch M; Jackson DG; Talikka M; Rauvala H; Betsholtz C; Alitalo K Nat Immunol; 2004 Jan; 5(1):74-80. PubMed ID: 14634646 [TBL] [Abstract][Full Text] [Related]
4. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients. Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190 [TBL] [Abstract][Full Text] [Related]
5. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis. Wong SY; Haack H; Crowley D; Barry M; Bronson RT; Hynes RO Cancer Res; 2005 Nov; 65(21):9789-98. PubMed ID: 16267000 [TBL] [Abstract][Full Text] [Related]
6. The significance of lymphatic space invasion and its association with vascular endothelial growth factor-C expression in ovarian cancer. Hisamatsu T; Mabuchi S; Sasano T; Kuroda H; Takahashi R; Matsumoto Y; Kawano M; Kozasa K; Takahashi K; Sawada K; Matsuo K; Tamada Y; Morii E; Kitadai Y; Kimura T Clin Exp Metastasis; 2015 Dec; 32(8):789-98. PubMed ID: 26443563 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor C disrupts the endothelial lymphatic barrier to promote colorectal cancer invasion. Tacconi C; Correale C; Gandelli A; Spinelli A; Dejana E; D'Alessio S; Danese S Gastroenterology; 2015 Jun; 148(7):1438-51.e8. PubMed ID: 25754161 [TBL] [Abstract][Full Text] [Related]
9. IGFBP7 functions as a potential lymphangiogenesis inducer in non-small cell lung carcinoma. Zhao W; Wang J; Zhu B; Duan Y; Chen F; Nian W; Sun J; Zhang B; Tong Z; Chen Z Oncol Rep; 2016 Mar; 35(3):1483-92. PubMed ID: 26706909 [TBL] [Abstract][Full Text] [Related]
10. Molecular control of lymphatic metastasis. Achen MG; Stacker SA Ann N Y Acad Sci; 2008; 1131():225-34. PubMed ID: 18519975 [TBL] [Abstract][Full Text] [Related]
11. Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling. He Y; Kozaki K; Karpanen T; Koshikawa K; Yla-Herttuala S; Takahashi T; Alitalo K J Natl Cancer Inst; 2002 Jun; 94(11):819-25. PubMed ID: 12048269 [TBL] [Abstract][Full Text] [Related]
12. Lymphangiogenesis and its relationship with lymphatic metastasis and prognosis in malignant melanoma. Liu B; Ma J; Wang X; Su F; Li X; Yang S; Ma W; Zhang Y Anat Rec (Hoboken); 2008 Oct; 291(10):1227-35. PubMed ID: 18561194 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Issa A; Le TX; Shoushtari AN; Shields JD; Swartz MA Cancer Res; 2009 Jan; 69(1):349-57. PubMed ID: 19118020 [TBL] [Abstract][Full Text] [Related]
14. The association of VEGF-C expression with tumor lymphatic vessel density and lymph node metastasis in patients with gastric cancer and gastrointestinal stromal tumor. Kigure W; Fujii T; Sutoh T; Morita H; Katoh T; Yajima RN; Yamaguchi S; Tsutsumi S; Asao T; Kuwano H Hepatogastroenterology; 2013; 60(122):277-80. PubMed ID: 23574654 [TBL] [Abstract][Full Text] [Related]
15. Opposing Roles of Vascular Endothelial Growth Factor C in Metastatic Dissemination and Resistance to Radio/Chemotherapy: Discussion of Mechanisms and Therapeutic Strategies. Montemagno C; Luciano F; Pagès G Methods Mol Biol; 2022; 2475():1-23. PubMed ID: 35451746 [TBL] [Abstract][Full Text] [Related]
16. Distinct roles of vascular endothelial growth factor-D in lymphangiogenesis and metastasis. Kopfstein L; Veikkola T; Djonov VG; Baeriswyl V; Schomber T; Strittmatter K; Stacker SA; Achen MG; Alitalo K; Christofori G Am J Pathol; 2007 Apr; 170(4):1348-61. PubMed ID: 17392173 [TBL] [Abstract][Full Text] [Related]
17. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Saharinen P; Tammela T; Karkkainen MJ; Alitalo K Trends Immunol; 2004 Jul; 25(7):387-95. PubMed ID: 15207507 [No Abstract] [Full Text] [Related]
19. Hypoxia inducible factor-1alpha correlates with VEGF-C expression and lymphangiogenesis in breast cancer. Schoppmann SF; Fenzl A; Schindl M; Bachleitner-Hofmann T; Nagy K; Gnant M; Horvat R; Jakesz R; Birner P Breast Cancer Res Treat; 2006 Sep; 99(2):135-41. PubMed ID: 16555123 [TBL] [Abstract][Full Text] [Related]
20. VEGF-C and VEGF-C156S in the pro-lymphangiogenic growth factor therapy of lymphedema: a large animal study. Visuri MT; Honkonen KM; Hartiala P; Tervala TV; Halonen PJ; Junkkari H; Knuutinen N; Ylä-Herttuala S; Alitalo KK; Saarikko AM Angiogenesis; 2015 Jul; 18(3):313-26. PubMed ID: 26018927 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]